RETROPHIN, INC.

Profile

Company Names

RETROPHIN, INC.

Addresses

777 THIRD AVENUE 22ND FLOOR, NEW YORK, NY 10017

Phone Numbers

646-837-5863

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$24,916,307.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2013-08-15 
$24,916,307.00 
$24,916,307.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
ASELAGE 
DIRECTOR
RETROPHIN, INC.   |  ACER THERAPEUTICS INC.   |  ACER THERAPEUTICS INC.
MARC 
 
PANOFF 
EXECUTIVE OFFICER
RETROPHIN, INC.   |  LB PHARMACEUTICALS INC.   |  LB PHARMACEUTICALS INC
HORACIO 
 
PLOTKIN 
EXECUTIVE OFFICER
RETROPHIN, INC.
STEVE 
 
RICHARDSON 
DIRECTOR
RETROPHIN, INC.   |  SYMMONETT EQUITY FUND I, LLC
MARTIN 
 
SHKRELI 
EXECUTIVE OFFICER, DIRECTOR
SUREPOINT INVESTMENT FUND LLC   |  RETROPHIN, INC.   |  KINDLY, INC   |  TURING PHARMACEUTICALS AG   |  GODEL SYSTEMS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-10-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-08-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
STIFEL, NICOLAUS + COMPANY, INCORPORATED
793
NONE
NONE
GUGGENHEIM SECURITIES, LLC
40638
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407